Welcome   (I'm not )
Select a date:

My Topics
Click here to add topics
Table bottom

My Companies
Click here to add companies
Table bottom

Industry News, A-Z
Table bottom

Google News
Table bottom

My Settings
Personal Info
Forgot Password?
Log out
Table bottom

Top Topics
No top stories
Table bottom

Top Topics
Financial Services & Investing
Aerospace & Defense
Infectious Disease
Freight & Air Courrier
Obesity, Weight Control & Nutrition
Oil & Gas
Computer Apps, Software & OS
Table bottom

Cancer & Oncolgy
Taiho Oncology, Inc. and Servier today announced clinical data for LONSURF® (trifluridine and tipiracil) for the treatment of patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluropyrimidine-, oxaliplatin-...
PR Newswire, 8:08am ET

Array BioPharma Inc. (Nasdaq: ARRY) and Pierre Fabre today announced updated results from the 30 patient safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a MEK...
PR Newswire, 10:13am ET

Going into the final floor routine of the night, the atmosphere in Hearnes Center was tense. No. 24 Missouri had held a narrow lead over No. 10 Arkansas all night, but after a strong beam performance from Arkansas, senior Kennedi Harris needed an...
University Wire, 7:08am ET

John Tunnel, founder and director of the Tunnell Insurance Agency, is announcing the launch of a charity event that promises to provide support to children in the Chicago area who are receiving medical treatment for cancer. Donations from this...
PRWeb, 8:08am ET

John Shepherd, owner and director of the Shepherd Insurance Agency in West Virginia, is announcing a charity drive to help raise awareness and support for pancreatic cancer survivors. Monies raised will be provided to the Pancreatic Cancer Action...
PRWeb, 8:08am ET

Today's Birthday (01/20/18). Professional opportunities abound this year. Discipline with spiritual practice and strategic planning pays off. Redirect a partnership this winter, before valuable personal discoveries illuminate a new path. Reach...
University Wire, 7:08am ET

SmarTrend identified a Downtrend for Newlink Genetics (NASDAQ:NLNK) on September 19th, 2017 at $11.77. In approximately 4 months, Newlink Genetics has returned 26.76% as of today's recent price of $8.62. In the past 52 weeks, Newlink...
Comtex SmarTrend(R), 4:58am ET

SmarTrend identified an Uptrend for Juno Therapeutic (NASDAQ:JUNO) on January 5th, 2018 at $48.79. In approximately 2 weeks, Juno Therapeutic has returned 38.98% as of today's recent price of $67.81. Juno Therapeutic share prices have...
Comtex SmarTrend(R), 4:43am ET

1-8 of 8

Tell a Friend About Us

Home Help My Settings Privacy Policy Terms of Service Advertising About Us Contact Us Logout

Copyright 1995-, No redistribution allowed.